Alzheimer Dementia (AD) Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Alzheimer Dementia (AD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study

Diabete Type 2Alzheimer Dementia (AD)
Rigshospitalet, Denmark60 enrolled1 locationNCT07482072
Recruiting
Phase 3

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

EpilepsyAlzheimer DiseaseSeizures+7 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau120 enrolled5 locationsNCT07234695
Recruiting
Not Applicable

Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function

Mild Cognitive Impairment (MCI)Alzheimer Dementia (AD)Subjective Cognitive Decline (SCD)
Aristotle University Of Thessaloniki128 enrolled1 locationNCT07289061
Recruiting
Phase 1

A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.

Alzheimer Dementia (AD)
Augusta University12 enrolled1 locationNCT07218081
Recruiting
Phase 2

Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia

Alzheimer DiseaseAlzheimer DementiaAlzheimer Dementia (AD)+3 more
Sunnybrook Health Sciences Centre12 enrolled1 locationNCT07279740
Recruiting
Phase 1

Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study

Mild Cognitive Impairment (MCI)Alzheimer Dementia (AD)
National University Hospital, Singapore48 enrolled1 locationNCT07210528
Recruiting
Phase 2

Transcranial Pulse Stimulation for Alzheimer's Disease

Alzheimer Dementia (AD)
Chinese University of Hong Kong40 enrolled1 locationNCT07143734
Recruiting

Investigating Genetic Status in Patients Presenting to Clinic

Alzheimer Dementia (AD)Lewy Body Dementia (LBD)Dementia, Frontotemporal
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1,000 enrolled1 locationNCT05911932